Literature DB >> 7065731

Conversion from daily to alternate daily corticosteroids in rheumatoid arthritis.

M A Fitzcharles, J Halsey, H L Currey.   

Abstract

An attempt was made to convert 24 patients on corticosteroid treatment from a daily to an alternate daily regimen. Ten patients were successfully converted, 11 failed to convert, and 3 had to be withdrawn for irrelevant reasons. A simple tetracosactrin stimulation test gave some indication of which patients were more likely to convert successfully. Success was not influenced by severity or duration of disease, nor by dose of duration of steroid therapy. Conversion did not influence various clinical and laboratory measures of undesirable steroid side effects, but the follow-up period was probably too short to judge this. The evidence of others suggests that conversion is worth attempting.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065731      PMCID: PMC1000866          DOI: 10.1136/ard.41.1.66

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  7 in total

1.  STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN.

Authors:  J G HARTER; W J REDDY; G W THORN
Journal:  N Engl J Med       Date:  1963-09-19       Impact factor: 91.245

2.  Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis.

Authors:  M K Jasani; J A Boyle; W R Greig; T G Dalakos; M C Browning; A Thompson; W W Buchanan
Journal:  Q J Med       Date:  1967-07

3.  Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections.

Authors:  D C Dale; A S Fauci; S M Wolff
Journal:  N Engl J Med       Date:  1974-11-28       Impact factor: 91.245

4.  Effect of alternate-day, single-dose, corticosteroid therapy on pituitary-adrenal function.

Authors:  M E Carter; V H James
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

5.  Alternate-day corticosteroid therapy in juvenile chronic polyarthritis.

Authors:  B M Ansell; E G Bywaters
Journal:  J Rheumatol       Date:  1974-06       Impact factor: 4.666

6.  Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects.

Authors:  R R MacGregor; J N Sheagren; M B Lipsett; S M Wolff
Journal:  N Engl J Med       Date:  1969-06-26       Impact factor: 91.245

7.  Alternate-day corticosteroid therapy.

Authors:  A S Fauci
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

  7 in total
  2 in total

Review 1.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.

Authors:  M Arnold; L Schrieber; P Brooks
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

2.  Advantages of an alternate-day glucocorticoid treatment strategy for the treatment of IgG4-related disease: A preliminary retrospective cohort study.

Authors:  Sho Fukui; Takehiro Nakai; Satoshi Kawaai; Yukihiko Ikeda; Masei Suda; Atsushi Nomura; Hiromichi Tamaki; Mitsumasa Kishimoto; Sachiko Ohde; Masato Okada
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.